⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for anaplastic pleomorphic xanthoastrocytoma

Every month we try and update this database with for anaplastic pleomorphic xanthoastrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsNCT02684058
Diffuse Astrocy...
Anaplastic Astr...
Astrocytoma
Oligodendroglio...
Anaplastic Olig...
Glioblastoma
Pilocytic Astro...
Giant Cell Astr...
Pleomorphic Xan...
Anaplastic Pleo...
Angiocentric Gl...
Chordoid Glioma...
Gangliocytoma
Ganglioglioma
Anaplastic Gang...
Dysplastic Gang...
Desmoplastic In...
Papillary Glion...
Rosette-forming...
Central Neurocy...
Extraventricula...
Cerebellar Ipon...
Dabrafenib
trametinib
Carboplatin
Vincristine
12 Months - 17 YearsNovartis
Pediatric Long-Term Follow-up and Rollover StudyNCT03975829
Diffuse Astrocy...
Anaplastic Astr...
Astrocytoma
Oligodendroglio...
Anaplastic Olig...
Glioblastoma
Pilocytic Astro...
Giant Cell Astr...
Pleomorphic Xan...
Anaplastic Pleo...
Angiocentric Gl...
Chordoid Glioma...
Gangliocytoma
Ganglioglioma
Anaplastic Gang...
Dysplastic Gang...
Desmoplastic In...
Papillary Glion...
Rosette-forming...
Central Neurocy...
Extraventricula...
Cerebellar Lipo...
Neurofibromatos...
dabrafenib
trametinib
1 Year - Novartis
Pediatric Long-Term Follow-up and Rollover StudyNCT03975829
Diffuse Astrocy...
Anaplastic Astr...
Astrocytoma
Oligodendroglio...
Anaplastic Olig...
Glioblastoma
Pilocytic Astro...
Giant Cell Astr...
Pleomorphic Xan...
Anaplastic Pleo...
Angiocentric Gl...
Chordoid Glioma...
Gangliocytoma
Ganglioglioma
Anaplastic Gang...
Dysplastic Gang...
Desmoplastic In...
Papillary Glion...
Rosette-forming...
Central Neurocy...
Extraventricula...
Cerebellar Lipo...
Neurofibromatos...
dabrafenib
trametinib
1 Year - Novartis
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsNCT02684058
Diffuse Astrocy...
Anaplastic Astr...
Astrocytoma
Oligodendroglio...
Anaplastic Olig...
Glioblastoma
Pilocytic Astro...
Giant Cell Astr...
Pleomorphic Xan...
Anaplastic Pleo...
Angiocentric Gl...
Chordoid Glioma...
Gangliocytoma
Ganglioglioma
Anaplastic Gang...
Dysplastic Gang...
Desmoplastic In...
Papillary Glion...
Rosette-forming...
Central Neurocy...
Extraventricula...
Cerebellar Ipon...
Dabrafenib
trametinib
Carboplatin
Vincristine
12 Months - 17 YearsNovartis
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsNCT04541082
Central Nervous...
Glioblastoma
Gliosarcoma, Ad...
Anaplastic Olig...
Anaplastic Astr...
Pilocytic Astro...
Oligodendroglio...
Gliomatosis Cer...
Pleomorphic Xan...
Anaplastic Pleo...
Diffuse Midline...
Ependymoma
Ependymoma, Ana...
Medulloblastoma
Teratoid Rhabdo...
Neuroectodermal...
Neuroectodermal...
Anaplastic Meni...
Atypical Mening...
Choroid Plexus ...
Pineal Tumor
Diffuse Astrocy...
Glial Tumor
ONC206
18 Years - Chimerix
Pediatric Long-Term Follow-up and Rollover StudyNCT03975829
Diffuse Astrocy...
Anaplastic Astr...
Astrocytoma
Oligodendroglio...
Anaplastic Olig...
Glioblastoma
Pilocytic Astro...
Giant Cell Astr...
Pleomorphic Xan...
Anaplastic Pleo...
Angiocentric Gl...
Chordoid Glioma...
Gangliocytoma
Ganglioglioma
Anaplastic Gang...
Dysplastic Gang...
Desmoplastic In...
Papillary Glion...
Rosette-forming...
Central Neurocy...
Extraventricula...
Cerebellar Lipo...
Neurofibromatos...
dabrafenib
trametinib
1 Year - Novartis
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaNCT03919071
Anaplastic Astr...
Anaplastic Astr...
Anaplastic Gang...
Anaplastic Pleo...
Glioblastoma
Malignant Gliom...
WHO Grade 3 Gli...
Biospecimen Col...
Dabrafenib Mesy...
Lumbar Puncture
Magnetic Resona...
Radiation Thera...
Trametinib Dime...
12 Months - 21 YearsNational Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: